KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Capital Employed (2016 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Return on Capital Employed for 17 consecutive years, with 0.13% as the latest value for Q1 2026.

  • For Q1 2026, Return on Capital Employed rose 5.0% year-over-year to 0.13%; the TTM value through Mar 2026 reached 0.13%, up 5.0%, while the annual FY2025 figure was 0.03%, 14.0% up from the prior year.
  • Return on Capital Employed hit 0.13% in Q1 2026 for Ionis Pharmaceuticals, up from 0.15% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.01% in Q3 2022 and bottomed at 0.22% in Q3 2023.
  • Average Return on Capital Employed over 5 years is 0.13%, with a median of 0.15% recorded in 2024.
  • Year-over-year, Return on Capital Employed rose 13bps in 2022 and then decreased -23bps in 2023.
  • Ionis Pharmaceuticals' Return on Capital Employed stood at 0.19% in 2022, then increased by 26bps to 0.14% in 2023, then dropped by -24bps to 0.17% in 2024, then grew by 12bps to 0.15% in 2025, then grew by 17bps to 0.13% in 2026.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.13%, 0.15%, and 0.13% for Q1 2026, Q4 2025, and Q3 2025 respectively.